Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
116.83
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Why ABBOTT LABORATORIES (NYSE:ABT) should be investigated by quality investors.
September 11, 2024
Is ABBOTT LABORATORIES (NYSE:ABT) a Strong Candidate for Quality Investing?
Via
Chartmill
2 Stocks That Are Passive Income Machines to Buy and Hold Forever
September 11, 2024
You can take these dividends straight to the bank.
Via
The Motley Fool
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
September 09, 2024
Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases
Via
MarketBeat
Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
September 05, 2024
Abbott recalls some FreeStyle Libre 3 sensors due to incorrect glucose readings, risking severe health issues.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
September 05, 2024
The companies are now duking it out for a new population of CGM users.
Via
Investor's Business Daily
Looking Into Abbott Laboratories's Recent Short Interest
August 29, 2024
Via
Benzinga
Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
August 22, 2024
Via
Benzinga
Patchy But Still Bullish
September 02, 2024
Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.
Via
Talk Markets
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
August 30, 2024
These three have secure core businesses, plus multiple paths to grow.
Via
The Motley Fool
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...
Via
Benzinga
Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients
August 26, 2024
DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a prescription. Designed for people with Type 2 diabetes and prediabetes, Stelo...
Via
Benzinga
Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?
August 26, 2024
The company is upbeat on its upcoming Stelo launch. The CGM is geared to people who don't use insulin.
Via
Investor's Business Daily
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
August 26, 2024
This MedTech leader is back on track with profitable growth.
Via
The Motley Fool
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
Some of Trump's Dividend Kings deserve a crown more than others.
Via
The Motley Fool
Topics
Government
Exposures
Political
3 Unstoppable Dividend Stocks to Buy Right Now
August 25, 2024
These stocks are the A-team for income investors.
Via
The Motley Fool
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
August 23, 2024
Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.
Via
MarketBeat
Exposures
Product Safety
Abbott Laboratories, Nu Holdings And More On CNBC's 'Final Trades'
August 22, 2024
Abbott Laboratories has a strong pipeline and the stock is starting to move, according to Karen Firestone of Aureus Asset Management.
Via
Benzinga
Looking for Safe Dividend Income? These 3 Stocks Have Rock-Solid Payouts.
August 17, 2024
These stocks pay above-average yields, and their dividend income could rise higher in the future.
Via
The Motley Fool
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
August 12, 2024
An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver.
Via
The Motley Fool
3 Stocks Retirees Should Absolutely Love
August 10, 2024
All of these stocks can provide steady income to retired investors.
Via
The Motley Fool
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
August 09, 2024
EQNX::TICKER_START (NYSE:OGEN),(NYSE:ABT),(NASDAQ:BIIB),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
3 Dividend Growth Stocks to Buy Hand Over Fist in August
August 07, 2024
There are blue-chip bargains paying large and growing dividends in the healthcare space.
Via
The Motley Fool
Large Cap Biopharma And Healthcare, A Port In A Storm
August 05, 2024
Healthcare and biopharma show nice gains in a volatile week.
Via
Talk Markets
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
August 05, 2024
Recent market pressure could worsen, but that won't stop these successful businesses from raising their dividend payouts.
Via
The Motley Fool
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
August 03, 2024
Dividend stocks are great; cheap dividend stocks are better.
Via
The Motley Fool
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
August 02, 2024
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users.
Via
Investor's Business Daily
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth
August 02, 2024
Abbott Laboratories' growth rate may look comparable to Johnson & Johnson's, but in the long run it could become much higher.
Via
The Motley Fool
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Via
InvestorPlace
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
July 31, 2024
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.